Altered expression pattern of topoisomerase IIα in ovarian tumor epithelial and stromal cells after platinum-based chemotherapy

被引:27
作者
Chekerov, Radoslav
Klaman, Irina
Zafrakas, Menelaos
Koensgen, Dominique
Mustea, Alexander
Petschke, Beate
Lichtenegger, Werner
Sehouli, Jalid
Dahl, Edgar
机构
[1] Univ Hosp, Rhein Westfal TH Aachen, Inst Pathol, D-52074 Aachen, Germany
[2] Charite Univ Hosp, Dept Obstet & Gynecol, Berlin, Germany
[3] Benjamin Franklin Univ Berlin, Inst Pathol, Berlin, Germany
来源
NEOPLASIA | 2006年 / 8卷 / 01期
关键词
TOP2A; ovarian cancer; RNA in situ hybridization; tumor stromal cells; chemotherapy resistance;
D O I
10.1593/neo.05580
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OBJECTIVE: The aim of this study was to evaluate the expression of topoisomerase II alpha (TOP2A) in epithelial and stromal cells of ovarian cancer. METHODS: TOP2A expression was analyzed in normal ovarian tissue and in laser-microdissected ovarian tumor epithelial and adjacent stromal cells using quantitative real time RT-PCR (n = 38), RNA in situ hybridization (n = 13), and immunhistochemistry (n = 69). Results: TOP2A mRNA was detected by RNA in situ hybridization in all ovarian cancer samples, with stronger hybridization signals in tumor epithelial cells compared to adjacent stromal cells. The same expression pattern was found by immunohistochemistry (P = .0001). Very interestingly, specific changes of TOP2A were found in recurrent ovarian cancer after platinum-based chemotherapy: TOP2A expression decreased in tumor epithelial cells (P = .056) of recurrent ovarian cancer, whereas it increased in tumor adjacent stromal cells (P = .023) compared to primary ovarian cancer. CONCLUSION: TOP2A mRNA and protein expressions in ovarian cancer exhibit specific patterns in tumor epithelial and adjacent stromal cells, which are differentially modulated after platinum-based chemotherapy. These data support the possible importance of the stromal compartment in tumor progression and suggest that tumor stromal cells might be relevant to the development of chemotherapy resistance in ovarian cancer.
引用
收藏
页码:38 / 45
页数:8
相关论文
共 49 条
[1]  
Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254
[2]   The role of molecular biology in understanding ovarian cancer initiation and progression [J].
Bingham, C ;
Roberts, D ;
Hamilton, TC .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2001, 11 :7-11
[3]   Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme [J].
Burden, DA ;
Osheroff, N .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :139-154
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]   Tumour-stromal interactions - Integrins and cell adhesions as modulators of mammary cell survival and transformation [J].
Chrenek, MA ;
Wong, P ;
Weaver, VM .
BREAST CANCER RESEARCH, 2001, 3 (04) :224-229
[6]   CHARACTERIZATION AND IMMUNOLOGICAL IDENTIFICATION OF CDNA CLONES ENCODING 2 HUMAN DNA TOPOISOMERASE-II ISOZYMES [J].
CHUNG, TDY ;
DRAKE, FH ;
TAN, KB ;
PER, SR ;
CROOKE, ST ;
MIRABELLI, CK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) :9431-9435
[7]   Second-line treatment and consolidation therapies in advanced ovarian cancer [J].
Conte, PF ;
Gadducci, A ;
Cianci, C .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2001, 11 :52-56
[8]  
Cornarotti M, 1996, INT J CANCER, V67, P479, DOI 10.1002/(SICI)1097-0215(19960807)67:4<479::AID-IJC3>3.0.CO
[9]  
2-P
[10]   Clinical resistance to topoisomerase-targeted drugs [J].
Dingemans, AMC ;
Pinedo, HM ;
Giaccone, G .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :275-288